Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

An immunologic portrait of cancer.

Ascierto ML, De Giorgi V, Liu Q, Bedognetti D, Spivey TL, Murtas D, Uccellini L, Ayotte BD, Stroncek DF, Chouchane L, Manjili MH, Wang E, Marincola FM.

J Transl Med. 2011 Aug 29;9:146. doi: 10.1186/1479-5876-9-146. Review.

2.

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

Galon J, Angell HK, Bedognetti D, Marincola FM.

Immunity. 2013 Jul 25;39(1):11-26. doi: 10.1016/j.immuni.2013.07.008. Review.

3.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
4.

Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Sartor RB.

Gastroenterol Clin North Am. 1995 Sep;24(3):475-507. Review.

PMID:
8809232
5.

Tumor immunosurveillance in human cancers.

Mlecnik B, Bindea G, Pagès F, Galon J.

Cancer Metastasis Rev. 2011 Mar;30(1):5-12. doi: 10.1007/s10555-011-9270-7. Review.

7.

The immunologic constant of rejection.

Wang E, Worschech A, Marincola FM.

Trends Immunol. 2008 Jun;29(6):256-62. doi: 10.1016/j.it.2008.03.002. Epub 2008 May 3. Review.

PMID:
18457994
8.

Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer.

Dalgleish AG, O'Byrne KJ.

Adv Cancer Res. 2002;84:231-76. Review.

PMID:
11883529
9.

Natural immunity to cancer in humans.

Bindea G, Mlecnik B, Fridman WH, Pagès F, Galon J.

Curr Opin Immunol. 2010 Apr;22(2):215-22. doi: 10.1016/j.coi.2010.02.006. Epub 2010 Mar 6. Review.

PMID:
20207124
10.

Immune predictors of cancer progression.

Toh B, Chew V, Dai X, Khoo K, Tham M, Wai LE, Hubert S, Velumani S, Zhi L, Huang C, Abastado JP.

Immunol Res. 2012 Sep;53(1-3):229-34. doi: 10.1007/s12026-012-8288-4. Review.

PMID:
22407576
11.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
12.

Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.

Coutinho A, Caramalho I, Seixas E, Demengeot J.

Curr Top Microbiol Immunol. 2005;293:43-71. Review.

PMID:
15981475
13.

Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms.

Demoulin S, Herfs M, Delvenne P, Hubert P.

J Leukoc Biol. 2013 Mar;93(3):343-52. doi: 10.1189/jlb.0812397. Epub 2012 Nov 7. Review.

14.

[Intratumoral immune microenvironment and survival: the immunoscore].

Galon J, Bindea G, Mlecnik B, Angell H, Lagorce C, Todosi AM, Berger A, Pagès F.

Med Sci (Paris). 2014 Apr;30(4):439-44. doi: 10.1051/medsci/20143004020. Epub 2014 May 5. Review. French.

15.

Immune infiltration in human cancer: prognostic significance and disease control.

Fridman WH, Galon J, Dieu-Nosjean MC, Cremer I, Fisson S, Damotte D, Pagès F, Tartour E, Sautès-Fridman C.

Curr Top Microbiol Immunol. 2011;344:1-24. doi: 10.1007/82_2010_46. Review.

PMID:
20512556
16.
17.
18.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949
19.

The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival.

He C, Qiao H, Jiang H, Sun X.

Clin Dev Immunol. 2011;2011:695834. doi: 10.1155/2011/695834. Epub 2011 Oct 13. Review.

20.

Tumor immune escape mechanisms that operate during metastasis.

Croci DO, Salatino M.

Curr Pharm Biotechnol. 2011 Nov;12(11):1923-36. Review.

PMID:
21470132
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk